Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized, double-blind, placebo-controlled trial of topical M528101 for postherpetic neuralgia
jRCT2031220415Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing M528101 0.3% topical with Vehicle placebo topical (2 arms). Started Nov 2022; status: completed.
02
Drugs
M528101
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2031220415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220415.